Investments Summarized Financial Information (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2020		Mar. 31, 2020	Jun. 30, 2019		Mar. 31, 2019
Schedule of Equity Method Investments [Line Items]
Gross loss	$ 10,267		$ 11,329		$ 21,251			$ 21,277
Loss from operations	(6,809)		(10,904)		(12,669)			(21,184)
Net loss attributable to NantOmics	$ (48,289)	$ 23,065	$ (14,713)	$ (19,923)	$ (25,224)	[1]		$ (34,636)	[1]
NantOmics
Schedule of Equity Method Investments [Line Items]
Revenues		126		1,320			$ 349			$ 3,066
Gross loss		(479)		(814)			(1,641)			(1,334)
Loss from operations		(3,950)		(6,221)			(7,806)			(13,105)
Impairment on equity investments		0		0			0			(12,265)
Net loss		(1,258)		(5,079)			(2,618)			(22,930)
Net loss attributable to NantOmics		$ (1,230)		$ (4,958)			$ (2,559)			$ (22,709)

[1] The statements for the six months ended June 30, 2020 and 2019 include the Connected Care Business (see Note 4).